 Green tea has been reported to have numerous health benefits, including reducing the risk of cancer, heart disease, and liver disease, due to its Cachin content, particularly epigalocaticin-3-galate. Studies show that green tea Cachins have underlying mechanisms and biological actions and can be used to treat metabolic syndrome, such as obesity, type 2 diabetes, and cardiovascular risk factors. Long-term consumption of tea Cachins may be beneficial against high-fat diet-induced obesity and type 2 diabetes, and reduce the risk of coronary disease. Further research is needed to monitor the pharmacological and clinical effects of green tea and elucidate its mechanisms of action. This article was offered by Kutun Ramadasan, Tambi Priya Tea, Choco Sabu M, and others.